Nelarabine is an antineoplastic purine nucleoside analog primarily indicated for the treatment of acute T-cell lymphoblastic leukemia. By inhibiting DNA synthesis through its conversion into active nucleotides,… Read more


















Nelarabine is an antineoplastic purine nucleoside analog primarily indicated for the treatment of acute T-cell lymphoblastic leukemia. By inhibiting DNA synthesis through its conversion into active nucleotides, this agent exerts cytotoxic effects on malignant cells. Pharmaceutical laboratories rely on this collection of Nelarabine reference standards, which encompasses pharmacopeial and non-pharmacopeial impurities, regioisomers, enantiomers, and stable isotope labelled compounds to ensure rigorous analysis. These materials are essential for conducting precise impurity profiling, supporting complex analytical testing methods, and facilitating robust method validation. By utilizing these specialized standards, analytical chemists can confirm molecular identity and maintain stringent quality control protocols throughout the production and evaluation of this chemotherapeutic agent.